Doug Gessl
Directeur Financier/CFO chez Ception Therapeutics, Inc.
Postes actifs de Doug Gessl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ception Therapeutics, Inc.
 Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Directeur Financier/CFO | - | - |
Historique de carrière de Doug Gessl
Anciens postes connus de Doug Gessl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Directeur des opérations | 19/07/2011 | - |
| Directeur Financier/CFO | 19/07/2011 | - | |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | - | - |
| Nesbitt Burns, Inc. | Corporate Officer/Principal | - | - |
| Tucker Anthony Sutro | Corporate Officer/Principal | - | - |
| Einhorn Associates, Inc. | Corporate Officer/Principal | - | - |
| Fulcrum Pharmaceuticals, Inc. | Directeur Administratif | - | - |
| Directeur Financier/CFO | - | - |
Formation de Doug Gessl
| The University of Chicago | Masters Business Admin |
| University of Wisconsin | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director of Finance/CFO | 3 |
| Masters Business Admin | 1 |
Sectorielle
| Finance | 5 |
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| Entreprise privées | 6 |
|---|---|
| Tucker Anthony Sutro | Finance |
| Fulcrum Pharmaceuticals, Inc. | Health Technology |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
| Nesbitt Burns, Inc. | Finance |
| Einhorn Associates, Inc. | Finance |
- Bourse
- Insiders
- Doug Gessl
- Expérience
